New Safe Use Requirements for Long-Acting Beta-Agonists (LABAs)

Feb 23, 201000:01:59Health

FDA is recommending new safety measures to improve the safe use of long acting beta agonists (LABAs).

Related Episodes

Continue listening to more episodes from FDA Drug Information Updates.

Jul 31, 2018 - 00:24:45

The FDA has made strides in improving transparency and data access, and has implemented tools to allow th...

May 4, 2018 - 00:02:59

The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for seizures a...

Jan 7, 2018 - 00:08:29

Oncologists Dr. Sanjeeve Bala and Dr. Abhilasha Nair from FDA’s Oncology Center of Excellence discuss the...

Jan 5, 2018 - 00:02:59

The FDA announced that it is requiring a new class warning and other safety measures for all gadolinium-b...

Jan 4, 2018 - 00:03:00

The FDA announced that a review of four large clinical safety trials shows that treating asthma with long...

Oct 29, 2017 - 00:09:22

Many listeners may be familiar with the FDA's Adverse Event Reporting System or FAERS. Data in FAERS supp...

Aug 17, 2017 - 00:05:29

FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complicatio...

Jul 28, 2017 - 00:06:00

FDA medical oncologists discuss the approval of osimertinib for EGFR mutation-positive non-small cell lun...